GURUFOCUS.COM » STOCK LIST » Basic Materials » Agriculture » Aristo Bio-Tech and Lifescience Ltd (NSE:ARISTO) » Definitions » Enterprise Value

Aristo Bio-Tech and Lifescience (NSE:ARISTO) Enterprise Value : ₹765 Mil (As of Jun. 14, 2024)


View and export this data going back to 2023. Start your Free Trial

What is Aristo Bio-Tech and Lifescience Enterprise Value?

Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Aristo Bio-Tech and Lifescience's Enterprise Value is ₹765 Mil. Aristo Bio-Tech and Lifescience's EBIT for the trailing twelve months (TTM) ended in Mar. 2023 was ₹69 Mil. Therefore, Aristo Bio-Tech and Lifescience's EV-to-EBIT ratio for today is 11.01.

EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, Aristo Bio-Tech and Lifescience's Enterprise Value is ₹765 Mil. Aristo Bio-Tech and Lifescience's EBITDA for the trailing twelve months (TTM) ended in Mar. 2023 was ₹85 Mil. Therefore, Aristo Bio-Tech and Lifescience's EV-to-EBITDA ratio for today is 9.02.

EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, Aristo Bio-Tech and Lifescience's Enterprise Value is ₹765 Mil. Aristo Bio-Tech and Lifescience's Revenue for the trailing twelve months (TTM) ended in Mar. 2023 was ₹2,178 Mil. Therefore, Aristo Bio-Tech and Lifescience's EV-to-Revenue ratio for today is 0.35.


Aristo Bio-Tech and Lifescience Enterprise Value Historical Data

The historical data trend for Aristo Bio-Tech and Lifescience's Enterprise Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aristo Bio-Tech and Lifescience Enterprise Value Chart

Aristo Bio-Tech and Lifescience Annual Data
Trend Mar20 Mar21 Mar22 Mar23
Enterprise Value
- - - 588.15

Aristo Bio-Tech and Lifescience Semi-Annual Data
Mar20 Mar21 Mar22 Sep22 Mar23
Enterprise Value - - - - 588.15

Competitive Comparison of Aristo Bio-Tech and Lifescience's Enterprise Value

For the Agricultural Inputs subindustry, Aristo Bio-Tech and Lifescience's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Aristo Bio-Tech and Lifescience's Enterprise Value Distribution in the Agriculture Industry

For the Agriculture industry and Basic Materials sector, Aristo Bio-Tech and Lifescience's Enterprise Value distribution charts can be found below:

* The bar in red indicates where Aristo Bio-Tech and Lifescience's Enterprise Value falls into.



Aristo Bio-Tech and Lifescience Enterprise Value Calculation

Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

Aristo Bio-Tech and Lifescience's Enterprise Value for the fiscal year that ended in Mar. 2023 is calculated as

Aristo Bio-Tech and Lifescience's Enterprise Value for the quarter that ended in Mar. 2023 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Aristo Bio-Tech and Lifescience  (NSE:ARISTO) Enterprise Value Explanation

When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.

If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.

The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.

For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.

Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.

1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.

Aristo Bio-Tech and Lifescience's EV-to-EBIT for today is

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=764.815/69.457
=11.01

Aristo Bio-Tech and Lifescience's current Enterprise Value is ₹765 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Aristo Bio-Tech and Lifescience's EBIT for the trailing twelve months (TTM) ended in Mar. 2023 was ₹69 Mil.

2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.

Aristo Bio-Tech and Lifescience's EV-to-EBITDA for today is:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA(TTM)
=764.815/84.82
=9.02

Aristo Bio-Tech and Lifescience's current Enterprise Value is ₹765 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Aristo Bio-Tech and Lifescience's EBITDA for the trailing twelve months (TTM) ended in Mar. 2023 was ₹85 Mil.

3. EV-to-Revenue is calculated as Enterprise Value divided by its Revenue.

Aristo Bio-Tech and Lifescience's EV-to-Revenue for today is:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=764.815/2178.45
=0.35

Aristo Bio-Tech and Lifescience's current Enterprise Value is ₹765 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Aristo Bio-Tech and Lifescience's Revenue for the trailing twelve months (TTM) ended in Mar. 2023 was ₹2,178 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Aristo Bio-Tech and Lifescience Enterprise Value Related Terms

Thank you for viewing the detailed overview of Aristo Bio-Tech and Lifescience's Enterprise Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Aristo Bio-Tech and Lifescience (NSE:ARISTO) Business Description

Traded in Other Exchanges
N/A
Address
E-24, 25, 26, G.I.D.C, Manjusar, Taluka Savli, Vadodara, GJ, IND, 391775
Aristo Bio-Tech and Lifescience Ltd is an agrochemical company. It is mainly engaged in the manufacturing, formulation, supplying, packaging, and job work services of various pesticides. The company exports products like Insecticides, Herbicides, Fungicides, Plant Growth Regulators, and a wide variety of other Agrochemicals.

Aristo Bio-Tech and Lifescience (NSE:ARISTO) Headlines

No Headlines